AD 128

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591046

CAS#: 25712-65-6

Description: AD 128 is bioactive chemical and a therapeutic agent.

Chemical Structure

img
AD 128
CAS# 25712-65-6
Instruction

Theoretical Analysis

MedKoo Cat#: 591046
Name: AD 128
CAS#: 25712-65-6
Chemical Formula: C17H23Cl2N3O2
Exact Mass: 371.12
Molecular Weight: 372.290
Elemental Analysis: C, 54.85; H, 6.23; Cl, 19.04; N, 11.29; O, 8.59

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: AD 128; AD128; AD-128

IUPAC/Chemical Name: Pyridinium, 4-tert-butyl-4'-formyl-1,1'-(oxydimethylene)di-, dichloride, oxime

InChi Key: MLMPXPZOSUGPPR-UHFFFAOYSA-M

InChi Code: InChI=1S/C17H22N3O2.2ClH/c1-17(2,3)16-6-10-20(11-7-16)14-22-13-19-8-4-15(5-9-19)12-18-21;;/h4-12H,13-14H2,1-3H3;2*1H/q+1;;/p-1

SMILES Code: CC(C1=CC=[N+](COC[N+]2=CC=C(/C=N/O)C=C2)C=C1)(C)C.[Cl-].[Cl-]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 372.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ingle JN, Kalari KR, Wickerham DL, von Minckwitz G, Fasching PA, Furukawa Y, Mushiroda T, Goetz MP, Barman P, Carlson EE, Rastogi P, Costantino JP, Cairns J, Paik S, Bear HD, Kubo M, Wang L, Wolmark N, Weinshilboum RM. Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab. Pharmacogenet Genomics. 2018 Jun;28(6):147-152. doi: 10.1097/FPC.0000000000000337. PubMed PMID: 29768301.

2: Maresova P, Tomsone S, Lameski P, Madureira J, Mendes A, Zdravevski E, Chorbev I, Trajkovik V, Ellen M, Rodile K. Technological Solutions for Older People with Alzheimer's Disease: Review. Curr Alzheimer Res. 2018 Apr 27. doi: 10.2174/1567205015666180427124547. [Epub ahead of print] PubMed PMID: 29701154.

3: Lee WR, Shen SC, Sung CT, Liu PY, Fang JY. Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models. Pharm Res. 2018 Apr 26;35(7):128. doi: 10.1007/s11095-018-2413-6. PubMed PMID: 29700662.

4: Palmer AM, Brandon TH. How do electronic cigarettes affect cravings to smoke or vape? Parsing the influences of nicotine and expectancies using the balanced-placebo design. J Consult Clin Psychol. 2018 May;86(5):486-491. doi: 10.1037/ccp0000303. PubMed PMID: 29683704.

5: Southworth T, Mason S, Bell A, Ramis I, Calbet M, Domenech A, Prats N, Miralpeix M, Singh D. PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge. Biomark Res. 2018 Apr 11;6:14. doi: 10.1186/s40364-018-0128-9. eCollection 2018. PubMed PMID: 29651336; PubMed Central PMCID: PMC5896031.

6: Gronqvist GV, Corner-Thomas RA, Kenyon PR, Stafford KJ, Morris ST, Hickson RE. The effect of nutrition and body condition of triplet-bearing ewes during late pregnancy on the behaviour of ewes and lambs. Asian-Australas J Anim Sci. 2018 Apr 12. doi: 10.5713/ajas.17.0890. [Epub ahead of print] PubMed PMID: 29642681.

7: Briars GL, Gordon GS, Lawrence A, Turner A, Perry S, Pillbrow D, Walston FE, Molyneux P. Swim drink study: a randomised controlled trial of during-exercise rehydration and swimming performance. BMJ Paediatr Open. 2017 Oct 25;1(1):e000075. doi: 10.1136/bmjpo-2017-000075. eCollection 2017. PubMed PMID: 29637116; PubMed Central PMCID: PMC5862197.

8: de Groot JF, Damen N, de Loos E, van de Steeg L, Koopmans L, Rosias P, Bruijn M, Goorhuis J, Wagner C. Implementing paediatric early warning scores systems in the Netherlands: future implications. BMC Pediatr. 2018 Apr 6;18(1):128. doi: 10.1186/s12887-018-1099-6. PubMed PMID: 29625600; PubMed Central PMCID: PMC5889599.

9: Lubbers M, van Det MJ, Kreuger MJ, Hoekstra R, Hendriksen EM, Vermeer M, Kouwenhoven EA. Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomes. J Surg Oncol. 2018 Mar;117(4):651-658. doi: 10.1002/jso.24935. PubMed PMID: 29603271.

10: Borchelt DR. Targeting the accomplice to thwart the culprit: a new target for the prevention of amyloid deposition. J Clin Invest. 2018 May 1;128(5):1734-1736. doi: 10.1172/JCI120414. Epub 2018 Mar 30. PubMed PMID: 29600962.

11: Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y, Finn MB, Hoyle R, Keyser J, Lefton KB, Robinson GO, Serrano JR, Silverman AP, Guo JL, Getz J, Henne K, Leyns CE, Gallardo G, Ulrich JD, Sullivan PM, Lerner EP, Hudry E, Sweeney ZK, Dennis MS, Hyman BT, Watts RJ, Holtzman DM. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest. 2018 May 1;128(5):2144-2155. doi: 10.1172/JCI96429. Epub 2018 Mar 30. PubMed PMID: 29600961.

12: Liu M, Cheng D, Wang K, Wang Y; Alzheimer’s Disease Neuroimaging Initiative. Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer's Disease Diagnosis. Neuroinformatics. 2018 Mar 23. doi: 10.1007/s12021-018-9370-4. [Epub ahead of print] PubMed PMID: 29572601.

13: Marin R, Diaz M. Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause. Front Neurosci. 2018 Mar 6;12:128. doi: 10.3389/fnins.2018.00128. eCollection 2018. Review. PubMed PMID: 29559883; PubMed Central PMCID: PMC5845729.

14: De Ciervo F, Willimburgh V, Finvarb G. [N-Methyl-D-Aspartate receptor encephalitis: An adolescent case report and literature review. How to manage neuropsychiatric symptoms]. Vertex. 2017 Mar;XXVIII(132):128-135. Spanish. PubMed PMID: 29522634.

15: Crous PW, Wingfield MJ, Burgess TI, Carnegie AJ, Hardy GESJ, Smith D, Summerell BA, Cano-Lira JF, Guarro J, Houbraken J, Lombard L, Martín MP, Sandoval-Denis M, Alexandrova AV, Barnes CW, Baseia IG, Bezerra JDP, Guarnaccia V, May TW, Hernández-Restrepo M, Stchigel AM, Miller AN, Ordoñez ME, Abreu VP, Accioly T, Agnello C, Agustin Colmán A, Albuquerque CC, Alfredo DS, Alvarado P, Araújo-Magalhães GR, Arauzo S, Atkinson T, Barili A, Barreto RW, Bezerra JL, Cabral TS, Camello Rodríguez F, Cruz RHSF, Daniëls PP, da Silva BDB, de Almeida DAC, de Carvalho Júnior AA, Decock CA, Delgat L, Denman S, Dimitrov RA, Edwards J, Fedosova AG, Ferreira RJ, Firmino AL, Flores JA, García D, Gené J, Giraldo A, Góis JS, Gomes AAM, Gonçalves CM, Gouliamova DE, Groenewald M, Guéorguiev BV, Guevara-Suarez M, Gusmão LFP, Hosaka K, Hubka V, Huhndorf SM, Jadan M, Jurjević Ž, Kraak B, Kučera V, Kumar TKA, Kušan I, Lacerda SR, Lamlertthon S, Lisboa WS, Loizides M, Luangsa-Ard JJ, Lysková P, Mac Cormack WP, Macedo DM, Machado AR, Malysheva EF, Marinho P, Matočec N, Meijer M, Mešić A, Mongkolsamrit S, Moreira KA, Morozova OV, Nair KU, Nakamura N, Noisripoom W, Olariaga I, Oliveira RJV, Paiva LM, Pawar P, Pereira OL, Peterson SW, Prieto M, Rodríguez-Andrade E, Rojo De Blas C, Roy M, Santos ES, Sharma R, Silva GA, Souza-Motta CM, Takeuchi-Kaneko Y, Tanaka C, Thakur A, Smith MT, Tkalčec Z, Valenzuela-Lopez N, van der Kleij P, Verbeken A, Viana MG, Wang XW, Groenewald JZ. Fungal Planet description sheets: 625-715. Persoonia. 2017 Dec;39:270-467. doi: 10.3767/persoonia.2017.39.11. Epub 2017 Dec 20. PubMed PMID: 29503478; PubMed Central PMCID: PMC5832955.

16: Kaye KS, Bhowmick T, Metallidis S, Bleasdale SC, Sagan OS, Stus V, Vazquez J, Zaitsev V, Bidair M, Chorvat E, Dragoescu PO, Fedosiuk E, Horcajada JP, Murta C, Sarychev Y, Stoev V, Morgan E, Fusaro K, Griffith D, Lomovskaya O, Alexander EL, Loutit J, Dudley MN, Giamarellos-Bourboulis EJ. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. JAMA. 2018 Feb 27;319(8):788-799. doi: 10.1001/jama.2018.0438. PubMed PMID: 29486041; PubMed Central PMCID: PMC5838656.

17: Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TLS, Johnson SC, Breitner JCS, Poirier J; Presymptomatic Evaluation of Novel or Experimental Treatments for Alzheimer Disease (PREVENT-AD) Research Group. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease. JAMA Neurol. 2018 Feb 26. doi: 10.1001/jamaneurol.2017.5135. [Epub ahead of print] PubMed PMID: 29482212.

18: Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP; Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study Group; Neurologic Outcomes Research Group (NORG). 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. 2018 Apr;128(4):728-744. doi: 10.1097/ALN.0000000000002103. PubMed PMID: 29389750; PubMed Central PMCID: PMC5849499.

19: Strickland S. Blood will out: vascular contributions to Alzheimer's disease. J Clin Invest. 2018 Feb 1;128(2):556-563. doi: 10.1172/JCI97509. Epub 2018 Feb 1. Review. PubMed PMID: 29388925; PubMed Central PMCID: PMC5785254.

20: Joseph JW, Chiu DT, Wong ML, Rosen CL, Nathanson LA, Sanchez LD. Experience Within the Emergency Department and Improved Productivity for First-Year Residents in Emergency Medicine and Other Specialties. West J Emerg Med. 2018 Jan;19(1):128-133. doi: 10.5811/westjem.2017.10.34819. Epub 2017 Dec 14. PubMed PMID: 29383067; PubMed Central PMCID: PMC5785179.